nodes	percent_of_prediction	percent_of_DWPC	metapath
Zanamivir—Pain—Thiotepa—urinary bladder cancer	0.0027	0.0027	CcSEcCtD
Zanamivir—Discomfort—Fluorouracil—urinary bladder cancer	0.0027	0.0027	CcSEcCtD
Zanamivir—Anaphylactoid reaction—Epirubicin—urinary bladder cancer	0.00268	0.00268	CcSEcCtD
Zanamivir—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.00266	0.00266	CcSEcCtD
Zanamivir—Infection—Gemcitabine—urinary bladder cancer	0.00264	0.00264	CcSEcCtD
Zanamivir—Confusional state—Fluorouracil—urinary bladder cancer	0.00264	0.00264	CcSEcCtD
Zanamivir—Convulsion—Cisplatin—urinary bladder cancer	0.00263	0.00263	CcSEcCtD
Zanamivir—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.00262	0.00262	CcSEcCtD
Zanamivir—Feeling abnormal—Thiotepa—urinary bladder cancer	0.00261	0.00261	CcSEcCtD
Zanamivir—Infection—Fluorouracil—urinary bladder cancer	0.0026	0.0026	CcSEcCtD
Zanamivir—Myalgia—Cisplatin—urinary bladder cancer	0.00259	0.00259	CcSEcCtD
Zanamivir—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.00259	0.00259	CcSEcCtD
Zanamivir—Skin disorder—Gemcitabine—urinary bladder cancer	0.00258	0.00258	CcSEcCtD
Zanamivir—Ill-defined disorder—Etoposide—urinary bladder cancer	0.00258	0.00258	CcSEcCtD
Zanamivir—Anxiety—Cisplatin—urinary bladder cancer	0.00258	0.00258	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—urinary bladder cancer	0.00257	0.00257	CcSEcCtD
Zanamivir—Discomfort—Cisplatin—urinary bladder cancer	0.00256	0.00256	CcSEcCtD
Zanamivir—Increased appetite—Doxorubicin—urinary bladder cancer	0.00255	0.00255	CcSEcCtD
Zanamivir—Anorexia—Gemcitabine—urinary bladder cancer	0.00254	0.00254	CcSEcCtD
Zanamivir—Urticaria—Thiotepa—urinary bladder cancer	0.00251	0.00251	CcSEcCtD
Zanamivir—Malaise—Etoposide—urinary bladder cancer	0.00251	0.00251	CcSEcCtD
Zanamivir—Face oedema—Epirubicin—urinary bladder cancer	0.0025	0.0025	CcSEcCtD
Zanamivir—Body temperature increased—Thiotepa—urinary bladder cancer	0.0025	0.0025	CcSEcCtD
Zanamivir—Abdominal pain—Thiotepa—urinary bladder cancer	0.0025	0.0025	CcSEcCtD
Zanamivir—Anorexia—Fluorouracil—urinary bladder cancer	0.00249	0.00249	CcSEcCtD
Zanamivir—Toxic epidermal necrolysis—Methotrexate—urinary bladder cancer	0.00249	0.00249	CcSEcCtD
Zanamivir—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.00248	0.00248	CcSEcCtD
Zanamivir—Anaphylactoid reaction—Doxorubicin—urinary bladder cancer	0.00248	0.00248	CcSEcCtD
Zanamivir—Infection—Cisplatin—urinary bladder cancer	0.00246	0.00246	CcSEcCtD
Zanamivir—Loss of consciousness—Etoposide—urinary bladder cancer	0.00245	0.00245	CcSEcCtD
Zanamivir—Cough—Etoposide—urinary bladder cancer	0.00243	0.00243	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.00242	0.00242	CcSEcCtD
Zanamivir—Convulsion—Etoposide—urinary bladder cancer	0.00241	0.00241	CcSEcCtD
Zanamivir—Dehydration—Epirubicin—urinary bladder cancer	0.00241	0.00241	CcSEcCtD
Zanamivir—Skin disorder—Cisplatin—urinary bladder cancer	0.00241	0.00241	CcSEcCtD
Zanamivir—Asthma—Methotrexate—urinary bladder cancer	0.00239	0.00239	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.00238	0.00238	CcSEcCtD
Zanamivir—Dyspnoea—Gemcitabine—urinary bladder cancer	0.00237	0.00237	CcSEcCtD
Zanamivir—Anorexia—Cisplatin—urinary bladder cancer	0.00236	0.00236	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.00235	0.00235	CcSEcCtD
Zanamivir—Discomfort—Etoposide—urinary bladder cancer	0.00234	0.00234	CcSEcCtD
Zanamivir—Toxic epidermal necrolysis—Epirubicin—urinary bladder cancer	0.00233	0.00233	CcSEcCtD
Zanamivir—Dyspnoea—Fluorouracil—urinary bladder cancer	0.00233	0.00233	CcSEcCtD
Zanamivir—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00233	0.00233	CcSEcCtD
Zanamivir—Face oedema—Doxorubicin—urinary bladder cancer	0.00231	0.00231	CcSEcCtD
Zanamivir—Decreased appetite—Gemcitabine—urinary bladder cancer	0.00231	0.00231	CcSEcCtD
Zanamivir—Fatigue—Gemcitabine—urinary bladder cancer	0.00229	0.00229	CcSEcCtD
Zanamivir—Confusional state—Etoposide—urinary bladder cancer	0.00229	0.00229	CcSEcCtD
Zanamivir—Pain—Gemcitabine—urinary bladder cancer	0.00228	0.00228	CcSEcCtD
Zanamivir—Decreased appetite—Fluorouracil—urinary bladder cancer	0.00227	0.00227	CcSEcCtD
Zanamivir—Anaphylactic shock—Etoposide—urinary bladder cancer	0.00227	0.00227	CcSEcCtD
Zanamivir—Asthenia—Thiotepa—urinary bladder cancer	0.00227	0.00227	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.00226	0.00226	CcSEcCtD
Zanamivir—Infection—Etoposide—urinary bladder cancer	0.00226	0.00226	CcSEcCtD
Zanamivir—Influenza—Epirubicin—urinary bladder cancer	0.00224	0.00224	CcSEcCtD
Zanamivir—Asthma—Epirubicin—urinary bladder cancer	0.00224	0.00224	CcSEcCtD
Zanamivir—Neutropenia—Methotrexate—urinary bladder cancer	0.00224	0.00224	CcSEcCtD
Zanamivir—Pain—Fluorouracil—urinary bladder cancer	0.00224	0.00224	CcSEcCtD
Zanamivir—Dehydration—Doxorubicin—urinary bladder cancer	0.00223	0.00223	CcSEcCtD
Zanamivir—Dyspnoea—Cisplatin—urinary bladder cancer	0.00221	0.00221	CcSEcCtD
Zanamivir—Skin disorder—Etoposide—urinary bladder cancer	0.00221	0.00221	CcSEcCtD
Zanamivir—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.00219	0.00219	CcSEcCtD
Zanamivir—Anorexia—Etoposide—urinary bladder cancer	0.00217	0.00217	CcSEcCtD
Zanamivir—Diarrhoea—Thiotepa—urinary bladder cancer	0.00216	0.00216	CcSEcCtD
Zanamivir—Toxic epidermal necrolysis—Doxorubicin—urinary bladder cancer	0.00216	0.00216	CcSEcCtD
Zanamivir—Decreased appetite—Cisplatin—urinary bladder cancer	0.00216	0.00216	CcSEcCtD
Zanamivir—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.00216	0.00216	CcSEcCtD
Zanamivir—Bronchitis—Epirubicin—urinary bladder cancer	0.00215	0.00215	CcSEcCtD
Zanamivir—Pain—Cisplatin—urinary bladder cancer	0.00212	0.00212	CcSEcCtD
Zanamivir—Stevens-Johnson syndrome—Methotrexate—urinary bladder cancer	0.00212	0.00212	CcSEcCtD
Zanamivir—Body temperature increased—Gemcitabine—urinary bladder cancer	0.0021	0.0021	CcSEcCtD
Zanamivir—Neutropenia—Epirubicin—urinary bladder cancer	0.00209	0.00209	CcSEcCtD
Zanamivir—Dizziness—Thiotepa—urinary bladder cancer	0.00209	0.00209	CcSEcCtD
Zanamivir—Urticaria—Fluorouracil—urinary bladder cancer	0.00208	0.00208	CcSEcCtD
Zanamivir—Influenza—Doxorubicin—urinary bladder cancer	0.00207	0.00207	CcSEcCtD
Zanamivir—Asthma—Doxorubicin—urinary bladder cancer	0.00207	0.00207	CcSEcCtD
Zanamivir—Body temperature increased—Fluorouracil—urinary bladder cancer	0.00207	0.00207	CcSEcCtD
Zanamivir—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00204	0.00204	CcSEcCtD
Zanamivir—Dyspnoea—Etoposide—urinary bladder cancer	0.00203	0.00203	CcSEcCtD
Zanamivir—Vomiting—Thiotepa—urinary bladder cancer	0.00201	0.00201	CcSEcCtD
Zanamivir—Rash—Thiotepa—urinary bladder cancer	0.00199	0.00199	CcSEcCtD
Zanamivir—Bronchitis—Doxorubicin—urinary bladder cancer	0.00199	0.00199	CcSEcCtD
Zanamivir—Dermatitis—Thiotepa—urinary bladder cancer	0.00199	0.00199	CcSEcCtD
Zanamivir—Headache—Thiotepa—urinary bladder cancer	0.00198	0.00198	CcSEcCtD
Zanamivir—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.00198	0.00198	CcSEcCtD
Zanamivir—Decreased appetite—Etoposide—urinary bladder cancer	0.00198	0.00198	CcSEcCtD
Zanamivir—Body temperature increased—Cisplatin—urinary bladder cancer	0.00196	0.00196	CcSEcCtD
Zanamivir—Fatigue—Etoposide—urinary bladder cancer	0.00196	0.00196	CcSEcCtD
Zanamivir—Pain—Etoposide—urinary bladder cancer	0.00194	0.00194	CcSEcCtD
Zanamivir—Neutropenia—Doxorubicin—urinary bladder cancer	0.00194	0.00194	CcSEcCtD
Zanamivir—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.00193	0.00193	CcSEcCtD
Zanamivir—Haemoglobin—Methotrexate—urinary bladder cancer	0.00193	0.00193	CcSEcCtD
Zanamivir—Haemorrhage—Methotrexate—urinary bladder cancer	0.00192	0.00192	CcSEcCtD
Zanamivir—Asthenia—Gemcitabine—urinary bladder cancer	0.00191	0.00191	CcSEcCtD
Zanamivir—Nausea—Thiotepa—urinary bladder cancer	0.00188	0.00188	CcSEcCtD
Zanamivir—Sinusitis—Epirubicin—urinary bladder cancer	0.00187	0.00187	CcSEcCtD
Zanamivir—Feeling abnormal—Etoposide—urinary bladder cancer	0.00187	0.00187	CcSEcCtD
Zanamivir—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.00186	0.00186	CcSEcCtD
Zanamivir—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.00183	0.00183	CcSEcCtD
Zanamivir—Hypersensitivity—Cisplatin—urinary bladder cancer	0.00183	0.00183	CcSEcCtD
Zanamivir—Diarrhoea—Gemcitabine—urinary bladder cancer	0.00182	0.00182	CcSEcCtD
Zanamivir—Erythema multiforme—Methotrexate—urinary bladder cancer	0.00181	0.00181	CcSEcCtD
Zanamivir—Urticaria—Etoposide—urinary bladder cancer	0.00181	0.00181	CcSEcCtD
Zanamivir—Haemoglobin—Epirubicin—urinary bladder cancer	0.0018	0.0018	CcSEcCtD
Zanamivir—Body temperature increased—Etoposide—urinary bladder cancer	0.0018	0.0018	CcSEcCtD
Zanamivir—Abdominal pain—Etoposide—urinary bladder cancer	0.0018	0.0018	CcSEcCtD
Zanamivir—Haemorrhage—Epirubicin—urinary bladder cancer	0.00179	0.00179	CcSEcCtD
Zanamivir—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00179	0.00179	CcSEcCtD
Zanamivir—Asthenia—Cisplatin—urinary bladder cancer	0.00178	0.00178	CcSEcCtD
Zanamivir—Sinusitis—Doxorubicin—urinary bladder cancer	0.00173	0.00173	CcSEcCtD
Zanamivir—Dizziness—Fluorouracil—urinary bladder cancer	0.00173	0.00173	CcSEcCtD
Zanamivir—Chills—Methotrexate—urinary bladder cancer	0.00172	0.00172	CcSEcCtD
Zanamivir—Diarrhoea—Cisplatin—urinary bladder cancer	0.0017	0.0017	CcSEcCtD
Zanamivir—Erythema multiforme—Epirubicin—urinary bladder cancer	0.0017	0.0017	CcSEcCtD
Zanamivir—Vomiting—Gemcitabine—urinary bladder cancer	0.00169	0.00169	CcSEcCtD
Zanamivir—Rash—Gemcitabine—urinary bladder cancer	0.00168	0.00168	CcSEcCtD
Zanamivir—Dermatitis—Gemcitabine—urinary bladder cancer	0.00168	0.00168	CcSEcCtD
Zanamivir—Hypersensitivity—Etoposide—urinary bladder cancer	0.00167	0.00167	CcSEcCtD
Zanamivir—Haemoglobin—Doxorubicin—urinary bladder cancer	0.00167	0.00167	CcSEcCtD
Zanamivir—Headache—Gemcitabine—urinary bladder cancer	0.00167	0.00167	CcSEcCtD
Zanamivir—Vomiting—Fluorouracil—urinary bladder cancer	0.00166	0.00166	CcSEcCtD
Zanamivir—Haemorrhage—Doxorubicin—urinary bladder cancer	0.00166	0.00166	CcSEcCtD
Zanamivir—Rash—Fluorouracil—urinary bladder cancer	0.00165	0.00165	CcSEcCtD
Zanamivir—Dermatitis—Fluorouracil—urinary bladder cancer	0.00165	0.00165	CcSEcCtD
Zanamivir—Headache—Fluorouracil—urinary bladder cancer	0.00164	0.00164	CcSEcCtD
Zanamivir—Asthenia—Etoposide—urinary bladder cancer	0.00163	0.00163	CcSEcCtD
Zanamivir—Chills—Epirubicin—urinary bladder cancer	0.00161	0.00161	CcSEcCtD
Zanamivir—Arrhythmia—Epirubicin—urinary bladder cancer	0.0016	0.0016	CcSEcCtD
Zanamivir—Nausea—Gemcitabine—urinary bladder cancer	0.00158	0.00158	CcSEcCtD
Zanamivir—Vomiting—Cisplatin—urinary bladder cancer	0.00158	0.00158	CcSEcCtD
Zanamivir—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.00157	0.00157	CcSEcCtD
Zanamivir—Rash—Cisplatin—urinary bladder cancer	0.00156	0.00156	CcSEcCtD
Zanamivir—Dermatitis—Cisplatin—urinary bladder cancer	0.00156	0.00156	CcSEcCtD
Zanamivir—Diarrhoea—Etoposide—urinary bladder cancer	0.00155	0.00155	CcSEcCtD
Zanamivir—Nausea—Fluorouracil—urinary bladder cancer	0.00155	0.00155	CcSEcCtD
Zanamivir—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.00155	0.00155	CcSEcCtD
Zanamivir—Malaise—Methotrexate—urinary bladder cancer	0.0015	0.0015	CcSEcCtD
Zanamivir—Dizziness—Etoposide—urinary bladder cancer	0.0015	0.0015	CcSEcCtD
Zanamivir—Chills—Doxorubicin—urinary bladder cancer	0.00149	0.00149	CcSEcCtD
Zanamivir—Arrhythmia—Doxorubicin—urinary bladder cancer	0.00148	0.00148	CcSEcCtD
Zanamivir—Nausea—Cisplatin—urinary bladder cancer	0.00147	0.00147	CcSEcCtD
Zanamivir—Cough—Methotrexate—urinary bladder cancer	0.00146	0.00146	CcSEcCtD
Zanamivir—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.00145	0.00145	CcSEcCtD
Zanamivir—Convulsion—Methotrexate—urinary bladder cancer	0.00144	0.00144	CcSEcCtD
Zanamivir—Vomiting—Etoposide—urinary bladder cancer	0.00144	0.00144	CcSEcCtD
Zanamivir—Agitation—Epirubicin—urinary bladder cancer	0.00143	0.00143	CcSEcCtD
Zanamivir—Rash—Etoposide—urinary bladder cancer	0.00143	0.00143	CcSEcCtD
Zanamivir—Dermatitis—Etoposide—urinary bladder cancer	0.00143	0.00143	CcSEcCtD
Zanamivir—Headache—Etoposide—urinary bladder cancer	0.00142	0.00142	CcSEcCtD
Zanamivir—Myalgia—Methotrexate—urinary bladder cancer	0.00142	0.00142	CcSEcCtD
Zanamivir—Arthralgia—Methotrexate—urinary bladder cancer	0.00142	0.00142	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.00141	0.00141	CcSEcCtD
Zanamivir—Malaise—Epirubicin—urinary bladder cancer	0.00141	0.00141	CcSEcCtD
Zanamivir—Discomfort—Methotrexate—urinary bladder cancer	0.0014	0.0014	CcSEcCtD
Zanamivir—Syncope—Epirubicin—urinary bladder cancer	0.0014	0.0014	CcSEcCtD
Zanamivir—Confusional state—Methotrexate—urinary bladder cancer	0.00137	0.00137	CcSEcCtD
Zanamivir—Loss of consciousness—Epirubicin—urinary bladder cancer	0.00137	0.00137	CcSEcCtD
Zanamivir—Cough—Epirubicin—urinary bladder cancer	0.00136	0.00136	CcSEcCtD
Zanamivir—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.00136	0.00136	CcSEcCtD
Zanamivir—Convulsion—Epirubicin—urinary bladder cancer	0.00135	0.00135	CcSEcCtD
Zanamivir—Infection—Methotrexate—urinary bladder cancer	0.00135	0.00135	CcSEcCtD
Zanamivir—Nausea—Etoposide—urinary bladder cancer	0.00135	0.00135	CcSEcCtD
Zanamivir—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.00134	0.00134	CcSEcCtD
Zanamivir—Myalgia—Epirubicin—urinary bladder cancer	0.00133	0.00133	CcSEcCtD
Zanamivir—Arthralgia—Epirubicin—urinary bladder cancer	0.00133	0.00133	CcSEcCtD
Zanamivir—Agitation—Doxorubicin—urinary bladder cancer	0.00133	0.00133	CcSEcCtD
Zanamivir—Anxiety—Epirubicin—urinary bladder cancer	0.00132	0.00132	CcSEcCtD
Zanamivir—Skin disorder—Methotrexate—urinary bladder cancer	0.00132	0.00132	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.00132	0.00132	CcSEcCtD
Zanamivir—Discomfort—Epirubicin—urinary bladder cancer	0.00131	0.00131	CcSEcCtD
Zanamivir—Malaise—Doxorubicin—urinary bladder cancer	0.0013	0.0013	CcSEcCtD
Zanamivir—Anorexia—Methotrexate—urinary bladder cancer	0.0013	0.0013	CcSEcCtD
Zanamivir—Syncope—Doxorubicin—urinary bladder cancer	0.00129	0.00129	CcSEcCtD
Zanamivir—Confusional state—Epirubicin—urinary bladder cancer	0.00128	0.00128	CcSEcCtD
Zanamivir—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.00127	0.00127	CcSEcCtD
Zanamivir—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.00127	0.00127	CcSEcCtD
Zanamivir—Infection—Epirubicin—urinary bladder cancer	0.00127	0.00127	CcSEcCtD
Zanamivir—Cough—Doxorubicin—urinary bladder cancer	0.00126	0.00126	CcSEcCtD
Zanamivir—Shock—Epirubicin—urinary bladder cancer	0.00125	0.00125	CcSEcCtD
Zanamivir—Convulsion—Doxorubicin—urinary bladder cancer	0.00125	0.00125	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.00124	0.00124	CcSEcCtD
Zanamivir—Skin disorder—Epirubicin—urinary bladder cancer	0.00124	0.00124	CcSEcCtD
Zanamivir—Myalgia—Doxorubicin—urinary bladder cancer	0.00123	0.00123	CcSEcCtD
Zanamivir—Arthralgia—Doxorubicin—urinary bladder cancer	0.00123	0.00123	CcSEcCtD
Zanamivir—Anxiety—Doxorubicin—urinary bladder cancer	0.00123	0.00123	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.00122	0.00122	CcSEcCtD
Zanamivir—Discomfort—Doxorubicin—urinary bladder cancer	0.00121	0.00121	CcSEcCtD
Zanamivir—Anorexia—Epirubicin—urinary bladder cancer	0.00121	0.00121	CcSEcCtD
Zanamivir—Dyspnoea—Methotrexate—urinary bladder cancer	0.00121	0.00121	CcSEcCtD
Zanamivir—Confusional state—Doxorubicin—urinary bladder cancer	0.00119	0.00119	CcSEcCtD
Zanamivir—Decreased appetite—Methotrexate—urinary bladder cancer	0.00118	0.00118	CcSEcCtD
Zanamivir—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.00118	0.00118	CcSEcCtD
Zanamivir—Fatigue—Methotrexate—urinary bladder cancer	0.00117	0.00117	CcSEcCtD
Zanamivir—Infection—Doxorubicin—urinary bladder cancer	0.00117	0.00117	CcSEcCtD
Zanamivir—Pain—Methotrexate—urinary bladder cancer	0.00116	0.00116	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.00116	0.00116	CcSEcCtD
Zanamivir—Shock—Doxorubicin—urinary bladder cancer	0.00116	0.00116	CcSEcCtD
Zanamivir—Skin disorder—Doxorubicin—urinary bladder cancer	0.00114	0.00114	CcSEcCtD
Zanamivir—Dyspnoea—Epirubicin—urinary bladder cancer	0.00114	0.00114	CcSEcCtD
Zanamivir—Anorexia—Doxorubicin—urinary bladder cancer	0.00112	0.00112	CcSEcCtD
Zanamivir—Feeling abnormal—Methotrexate—urinary bladder cancer	0.00112	0.00112	CcSEcCtD
Zanamivir—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.00111	0.00111	CcSEcCtD
Zanamivir—Decreased appetite—Epirubicin—urinary bladder cancer	0.00111	0.00111	CcSEcCtD
Zanamivir—Fatigue—Epirubicin—urinary bladder cancer	0.0011	0.0011	CcSEcCtD
Zanamivir—Pain—Epirubicin—urinary bladder cancer	0.00109	0.00109	CcSEcCtD
Zanamivir—Urticaria—Methotrexate—urinary bladder cancer	0.00108	0.00108	CcSEcCtD
Zanamivir—Abdominal pain—Methotrexate—urinary bladder cancer	0.00108	0.00108	CcSEcCtD
Zanamivir—Body temperature increased—Methotrexate—urinary bladder cancer	0.00108	0.00108	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.00107	0.00107	CcSEcCtD
Zanamivir—Dyspnoea—Doxorubicin—urinary bladder cancer	0.00105	0.00105	CcSEcCtD
Zanamivir—Feeling abnormal—Epirubicin—urinary bladder cancer	0.00105	0.00105	CcSEcCtD
Zanamivir—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.00104	0.00104	CcSEcCtD
Zanamivir—Decreased appetite—Doxorubicin—urinary bladder cancer	0.00102	0.00102	CcSEcCtD
Zanamivir—Fatigue—Doxorubicin—urinary bladder cancer	0.00102	0.00102	CcSEcCtD
Zanamivir—Urticaria—Epirubicin—urinary bladder cancer	0.00101	0.00101	CcSEcCtD
Zanamivir—Pain—Doxorubicin—urinary bladder cancer	0.00101	0.00101	CcSEcCtD
Zanamivir—Body temperature increased—Epirubicin—urinary bladder cancer	0.00101	0.00101	CcSEcCtD
Zanamivir—Abdominal pain—Epirubicin—urinary bladder cancer	0.00101	0.00101	CcSEcCtD
Zanamivir—Hypersensitivity—Methotrexate—urinary bladder cancer	0.001	0.001	CcSEcCtD
Zanamivir—Asthenia—Methotrexate—urinary bladder cancer	0.000976	0.000976	CcSEcCtD
Zanamivir—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000971	0.000971	CcSEcCtD
Zanamivir—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000964	0.000964	CcSEcCtD
Zanamivir—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000938	0.000938	CcSEcCtD
Zanamivir—Urticaria—Doxorubicin—urinary bladder cancer	0.000936	0.000936	CcSEcCtD
Zanamivir—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000932	0.000932	CcSEcCtD
Zanamivir—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000932	0.000932	CcSEcCtD
Zanamivir—Diarrhoea—Methotrexate—urinary bladder cancer	0.000931	0.000931	CcSEcCtD
Zanamivir—Asthenia—Epirubicin—urinary bladder cancer	0.000914	0.000914	CcSEcCtD
Zanamivir—Dizziness—Methotrexate—urinary bladder cancer	0.0009	0.0009	CcSEcCtD
Zanamivir—Diarrhoea—Epirubicin—urinary bladder cancer	0.000871	0.000871	CcSEcCtD
Zanamivir—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000868	0.000868	CcSEcCtD
Zanamivir—Vomiting—Methotrexate—urinary bladder cancer	0.000865	0.000865	CcSEcCtD
Zanamivir—Rash—Methotrexate—urinary bladder cancer	0.000858	0.000858	CcSEcCtD
Zanamivir—Dermatitis—Methotrexate—urinary bladder cancer	0.000857	0.000857	CcSEcCtD
Zanamivir—Headache—Methotrexate—urinary bladder cancer	0.000853	0.000853	CcSEcCtD
Zanamivir—Asthenia—Doxorubicin—urinary bladder cancer	0.000846	0.000846	CcSEcCtD
Zanamivir—Dizziness—Epirubicin—urinary bladder cancer	0.000842	0.000842	CcSEcCtD
Zanamivir—Vomiting—Epirubicin—urinary bladder cancer	0.00081	0.00081	CcSEcCtD
Zanamivir—Nausea—Methotrexate—urinary bladder cancer	0.000808	0.000808	CcSEcCtD
Zanamivir—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000806	0.000806	CcSEcCtD
Zanamivir—Rash—Epirubicin—urinary bladder cancer	0.000803	0.000803	CcSEcCtD
Zanamivir—Dermatitis—Epirubicin—urinary bladder cancer	0.000802	0.000802	CcSEcCtD
Zanamivir—Headache—Epirubicin—urinary bladder cancer	0.000798	0.000798	CcSEcCtD
Zanamivir—Dizziness—Doxorubicin—urinary bladder cancer	0.000779	0.000779	CcSEcCtD
Zanamivir—Nausea—Epirubicin—urinary bladder cancer	0.000757	0.000757	CcSEcCtD
Zanamivir—Vomiting—Doxorubicin—urinary bladder cancer	0.000749	0.000749	CcSEcCtD
Zanamivir—Rash—Doxorubicin—urinary bladder cancer	0.000743	0.000743	CcSEcCtD
Zanamivir—Dermatitis—Doxorubicin—urinary bladder cancer	0.000742	0.000742	CcSEcCtD
Zanamivir—Headache—Doxorubicin—urinary bladder cancer	0.000738	0.000738	CcSEcCtD
Zanamivir—Nausea—Doxorubicin—urinary bladder cancer	0.0007	0.0007	CcSEcCtD
